IOVS Journal of Clinical Investigation
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Renno, R. Z.
Right arrow Articles by Miller, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Renno, R. Z.
Right arrow Articles by Miller, J. W.
(Investigative Ophthalmology and Visual Science. 2000;41:3963-3971.)
© 2000 by The Association for Research in Vision and Ophthalmology, Inc.

Photodynamic Therapy Using Lu-Tex Induces Apoptosis In Vitro, and Its Effect Is Potentiated by Angiostatin in Retinal Capillary Endothelial Cells

Reem Z. Renno1, Francois C. Delori2, Robin A. Holzer1, Evangelos S. Gragoudas1 and Joan W. Miller1

1 From the Laser Laboratory, Retina Service, Massachusetts Eye and Ear Infirmary; and the 2 Schepens Eye Research Institute, Harvard Medical School, Boston.

PURPOSE. To examine the effect of combining angiostatin with photodynamic therapy (PDT) using Lutetium Texaphyrin (Lu-Tex; Alcon, Fort Worth, TX) as a photosensitizer in bovine retinal capillary endothelial (BRCE) and retinal pigment epithelial (RPE) cells and to determine the mode of PDT-induced cell death in these cell lines.

METHODS. Cultured BRCE and RPE cells were incubated with angiostatin (500 ng/ml) for 18 hours and subjected to Lu-Tex/PDT, using treatment parameters previously optimized (3 µg/ml Lu-Tex for 30 minutes followed by timed irradiation at 732 nm). Cellular survival was assessed after a 1-week cellular proliferation. Data were analyzed using Student’s t-test. Caspase 3 activity was monitored in cells after PDT using a fluorogenic substrate, (Asp-Glu-Val-Asp)-AFC (7-amino-4-trifluoromethyl coumarin) [DEVD-AFC], of caspase 3. After PDT, expression of Bcl-2, Bcl-xL, Bax, and Bak was also examined in cell lysates by Western blot analysis.

RESULTS. A synergistic cytotoxic effect of angiostatin and Lu-Tex/PDT was observed in BRCE cells at all fluences used (5, 10, and 20 J/cm2; P <= 0.05). These findings applied only if angiostatin was delivered before PDT. No such interactive killing effect was observed in RPE cells. Caspase 3 activity was elevated within 10 minutes of PDT in BRCE and RPE cells and was fluence dependent. Differential modulation of Bcl-2 family members was observed after PDT in BRCE and RPE cells.

CONCLUSIONS. The combination of angiostatin and Lu-Tex/PDT potentiates the cytotoxic effect of Lu-Tex/PDT on BRCE but not on RPE cells. This may provide a strategy to increase the selectivity of PDT in damaging capillary endothelial cells with less damage to RPE cells. Lu-Tex/PDT induces rapid caspase-dependent apoptosis in BRCE and RPE cells. Furthermore, Lu-Tex/PDT induces apoptosis through selective modulation of members of the Bcl-2 family and differs between BRCE and RPE cells.




This article has been cited by other articles:


Home page
IOVSHome page
M. Berdugo, R. A. Bejjani, F. Valamanesh, M. Savoldelli, J.-C. Jeanny, D. Blanc, H. Ficheux, A. Scherz, Y. Salomon, D. BenEzra, et al.
Evaluation of the New Photosensitizer Stakel (WST-11) for Photodynamic Choroidal Vessel Occlusion in Rabbit and Rat Eyes
Invest. Ophthalmol. Vis. Sci., April 1, 2008; 49(4): 1633 - 1644.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
A. Matsubara, T. Nakazawa, K. Noda, H. She, E. Connolly, T. A. Young, Y. Ogura, E. S. Gragoudas, and J. W. Miller
Photodynamic Therapy Induces Caspase-Dependent Apoptosis in Rat CNV Model
Invest. Ophthalmol. Vis. Sci., October 1, 2007; 48(10): 4741 - 4747.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
D. Husain, I. Kim, D. Gauthier, A. M. Lane, M. K. Tsilimbaris, E. Ezra, E. J. Connolly, N. Michaud, E. S. Gragoudas, C. A. O'Neill, et al.
Safety and Efficacy of Intravitreal Injection of Ranibizumab in Combination With Verteporfin PDT on Experimental Choroidal Neovascularization in the Monkey
Arch Ophthalmol, April 1, 2005; 123(4): 509 - 516.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
R. Z. Renno, Y. Terada, M. J. Haddadin, N. A. Michaud, E. S. Gragoudas, and J. W. Miller
Selective Photodynamic Therapy by Targeted Verteporfin Delivery to Experimental Choroidal Neovascularization Mediated by a Homing Peptide to Vascular Endothelial Growth Factor Receptor-2
Arch Ophthalmol, July 1, 2004; 122(7): 1002 - 1011.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
D. N. Zacks, E. Ezra, Y. Terada, N. Michaud, E. Connolly, E. S. Gragoudas, and J. W. Miller
Verteporfin Photodynamic Therapy in the Rat Model of Choroidal Neovascularization: Angiographic and Histologic Characterization
Invest. Ophthalmol. Vis. Sci., July 1, 2002; 43(7): 2384 - 2391.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the Association for Research in Vision and Ophthalmology